Search

Your search keyword '"G. Lubec"' showing total 68 results

Search Constraints

Start Over You searched for: Author "G. Lubec" Remove constraint Author: "G. Lubec" Publisher elsevier Remove constraint Publisher: elsevier
68 results on '"G. Lubec"'

Search Results

1. Spheroid glioblastoma culture conditions as antigen source for dendritic cell-based immunotherapy: spheroid proteins are survival-relevant targets but can impair immunogenic interferon γ production.

2. Synaptic proteome changes in the hypothalamus of mother rats.

3. Widespread alterations in the synaptic proteome of the adolescent cerebral cortex following prenatal immune activation in rats.

4. Proteomic analysis of the TerC interactome: Novel links to tellurite resistance and pathogenicity.

5. Synaptic mitochondria: a brain mitochondria cluster with a specific proteome.

6. Different expression of membrane-bound and cytosolic hippocampal steroid receptor complexes during spatial training in young male rats.

7. Structure and post-translational modifications of the web silk protein spidroin-1 from Nephila spiders.

8. Characterization of α-l-Iduronidase (Aldurazyme®) and its complexes.

9. Network of brain protein level changes in glutaminase deficient fetal mice.

10. An electrophoretic approach to screen for glutamine deamidation.

11. Mass spectrometrical analysis of cuticular proteins from the wing of Hebemoia glaucippe (Linnaeus, 1758) (Lepidoptera: Pieridae).

12. A gel-based proteomic method reveals several protein pathway abnormalities in fetal Down syndrome brain.

13. Comparison of fluorescent labels for oligosaccharides and introduction of a new postlabeling purification method.

14. Start-to-end processing of two-dimensional gel electrophoretic images.

15. Limitations of current proteomics technologies.

16. The rat brain hippocampus proteome.

17. Impaired cognitive performance in neuronal nitric oxide synthase knockout mice is associated with hippocampal protein derangements.

18. Expressional pattern of known and predicted signaling proteins in seven human cell lines.

19. Neurogenic cells in human amniotic fluid.

20. Protein profile of the HeLa cell line.

21. Neuronal nitric oxide synthase knock-out mice show impaired cognitive performance.

22. Tuberous sclerosis genes regulate cellular 14-3-3 protein levels.

23. Regulation of PCNA and CAF-1 expression by the two tuberous sclerosis gene products.

24. Human brain nucleoside diphosphate kinase activity is decreased in Alzheimer's disease and Down syndrome.

25. Reduction of actin-related protein complex 2/3 in fetal Down syndrome brain.

26. Aberrant expression of centractin and capping proteins, integral constituents of the dynactin complex, in fetal down syndrome brain.

27. Increased kynurenic acid in the brain after neonatal asphyxia.

28. Decreased brain levels of 2',3'-cyclic nucleotide-3'-phosphodiesterase in Down syndrome and Alzheimer's disease.

29. The reduction of NADH ubiquinone oxidoreductase 24- and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer's disease.

30. Brain fatty acids in perinatal asphyxia.

31. Differential display reveals downregulation of the phospholipid transfer protein (PLTP) at the mRNA level in brains of patients with Down syndrome.

32. Alteration of caspases and apoptosis-related proteins in brains of patients with Alzheimer's disease.

33. Deranged expression of molecular chaperones in brains of patients with Alzheimer's disease.

34. Effects of transdermal nicotine on cognitive performance in Down's syndrome.

35. Neuroendocrine-specific protein C, a marker of neuronal differentiation, is reduced in brain of patients with Down syndrome and Alzheimer's disease.

36. Energy metabolism in graded perinatal asphyxia of the rat.

37. Long term neurological and behavioral effects of graded perinatal asphyxia in the rat.

38. Evidence against the current hypothesis of "gene dosage effects" of trisomy 21: ets-2, encoded on chromosome 21" is not overexpressed in hearts of patients with Down Syndrome.

39. Thyroid stimulating hormone-receptor overexpression in brain of patients with Down syndrome and Alzheimer's disease.

40. Increased steady state mRNA levels of DNA-repair genes XRCC1, ERCC2 and ERCC3 in brain of patients with Down syndrome.

41. Genes involved in the pathophysiology of perinatal asphyxia.

42. Oral administration of methylglyoxal leads to kidney collagen accumulation in the mouse.

43. Thioredoxin from Streptomyces aureofaciens controls coiling of plasmid DNA.

44. cAMP upregulates the transposable element mys-1: a possible link between signaling and mobile DNA.

45. Evidence for the involvement of the hydroxyl radical in the pathogenesis of excessive connective tissue proliferation in patients with tumor-endoprostheses.

46. Reactivity of homocysteine-thiolactone and alpha-methylhomocysteine-thiolactone with e-(aq) and OH-radical: a pulse radiolysis study.

47. Distribution and disappearance of the radiolabeled carbon derived from L-arginine and taurine in the mouse.

48. The transcription of the XRCC1 gene in spleen following ionizing irradiation in radiosensitive and radioresistant mice.

49. Radiation protection by alpha-methyl-homocysteine thiolactone in vitro.

50. The effect of estradiol and ovariectomy on tyrosine hydroxylase, tyrosine aminotransferase and phenylalanine hydroxylase.

Catalog

Books, media, physical & digital resources